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Abstract
Background: Medication non-adherence is a major public health
issue, creating obstacles to effective treatment of hypertension.
Examining the underlying factors of deliberate and non-deliberate
non-adherence is crucial to address this problem. Thus, the goal of the
present study is to assess the socio-demographic, clinical and psycho-
logical determinants of intentional and unintentional non-adherence.
Design and methods: A cross-sectional survey was conducted
between March, 2015 and April, 2016. The sample consisted of hyper-
tension patients holding at least one medical prescription (N=109).
Measurements assessed patients’ medication adherence, health liter-
acy, empowerment, self-efficacy, medication beliefs, and patients’
acceptance of their doctor’s advice, socio-demographic and clinical
characteristics.
Results: Patients who occasionally engaged in either intentional or
unintentional non-adherence reported to have lower adherence self-
efficacy, higher medication concern beliefs, lower meaningfulness
scores and were less likely to accept the doctor’s treatment recommen-
dations. Patients who occasionally engaged in unintentional non-
adherence were younger and had experienced more side effects com-
pared to completely adherent patients. Adherence self-efficacy was a
mediator of the effect of health literacy on patients’ medication adher-
ence and acceptance of the doctor’s advice was a covariate.
Conclusions: Regarding the research implications, health literacy
and adherence self-efficacy should be assessed simultaneously when
investigating the factors of non-adherence. Regarding the practical
implications, adherence could be increased if physicians i) double-
check whether their patients accept the treatment advice given and ii)
if they address patients’ concerns about medications. These steps
could be especially important for patients characterized with lower
self-efficacy, as they are more likely to engage in occasional non-
adherence.
Introduction
Medication non-adherence constitutes a significant obstacle to
hypertension care with a prevalence between 20% and 50%.1 Non-
adherence is a complex phenomenon having a broad range of determi-
nants, which can be grouped into patient-, physician-, medication- and
health care system-related factors.2,3 In our study, we focus on the
patient-related factors of medication non-adherence. In particular, we
follow the precepts of the Health Empowerment Model,4 which advo-
cates that health literacy and patient empowerment are interconnect-
ed but are also quite distinct predictors of various health behaviours.5
However, the interplay between health literacy and empowerment in a
medication adherence context has not yet been tested.
Health literacy  which refers to the degree to which individuals have
the capacity to obtain, process, and understand basic health informa-
tion and services needed to make appropriate health decisions6  is one
of the patient-related factors of adherence. Two meta-analyses involv-
ing various patient groups unequivocally concluded that there was a
statistically significant but weak relationship between health literacy
and adherence. However, the evidence is mixed concerning cardiovas-
cular patients, as some studies reported that low health literacy was
associated with poor adherence, while others studies found no signif-
icant relationship.7,8 It is worth noting that the majority of the studies
operationalized health literacy as basic numeracy and reading skills or
health-related knowledge, but relatively little research has been done
on its complex cognitive components, such as judgment skills. The
term judgment skills refers to one’s ability to examine one’s own capa-
bilities and limitations in order to make appropriate health decisions.9
The beneficial effect of proper judgment skills on disease management
has been well documented,10,11 but its effect on medication adherence
has not yet been addressed.
Psychological empowerment is conceived as the patients’ willing-
ness to act as autonomous actors taking increased responsibility for
their own medical decision-making.12 Patient empowerment is a four
dimensional concept: 1. Meaningfulness (refers to the value of activi-
ties worth investing energy in), 2. Impact (belief that one’s actions can
make a difference), 3. Self-determination (refers to making
autonomous choices) and 4. Competence (belief in one’s own capabil-
ities to implement activities).4 Self-efficacy, which is closely related to
the empowerment concept, is the most prominent determinant of
adherence across conditions within the socio-cognitive and self-regu-
lation theories.13 Medication beliefs  are also important determinants
of adherence.13-16 Those who endorse the belief that a certain medica-
tion is necessary for their health appear to be much more adherent
than those who do not hold this belief. Conversely, people who endorse
concern beliefs about their medication are less likely to be adherent
compared to those who do not hold any concern beliefs.15
Beyond personal characteristics, certain aspects of the doctor-
patient relationship can also influence patients’ medication adher-
ence. For instance, patients’ acceptance of treatment advice, which is
Significance for public health
Medication non-adherence is a critical public health issue, leading to increased
health care costs, morbidity and mortality across several chronic conditions.
Medication non-adherence is also one of the main obstacles to effective hyper-
tension care, as between 20-50% of the patients do not follow appropriately
their prescribed medication regimen. Despite the large body of empirical evi-
dence available, relatively little is known about the potential differences
between the determinants underpinning intentional versus unintentional non-
adherence. Shedding light on the factors of medication non-adherence is
inevitable to develop interventions and health campaigns addressing the issue.
Thus, the present study quantitatively examines the patient-related factors of
medication non-adherence to antihypertensive drugs, distinguishing between
the determinants of deliberate versus non-deliberate non-adherence.
Moreover, based on the outcomes, we advocate potential new approaches to
address medication non-adherence in hypertension.
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a proxy of the extent of patient’s commitment, might also have an
impact on medication adherence. Indeed, in an experimental setting, a
positive link was seen between the participants’ acceptance of medical
advice and their intention to adhere to the given recommendation.17
However, whether this effect would hold true in a real-life setting has
not yet been investigated.
The goal of the present article is to examine the clinical, cognitive
and psychological determinants of medication adherence in hyperten-
sion. Moreover, we compared the determinants of intentional versus
unintentional non-adherence, as the underpinning factors might sig-
nificantly differ.18 We tested the assumption of the Health
Empowerment Model, to see if health literacy and empowerment are
distinct but intertwined predictors of medication adherence.
Additionally, we examined the role of medication beliefs and self-effi-
cacy in explaining adherence. In particular, we examined context-spe-
cific adherence self-efficacy beliefs, i.e. those closely linked to one’s
beliefs about one’s own capacity to follow a prescribed medication reg-
imen in challenging situations.19 Finally, we tested whether patients’
acceptance of their doctor’s medical advice can affect behavioural
adherence.
Design and MethodsData collection
The study applied a cross-sectional design. The questionnaires were
pretested for face and content validity with a health care professional
and patients respectively. The participants were recruited with the help
of medical offices and hospitals. The data collection took place over the
time period between March, 2015 and April, 2016. In order to partici-
pate in the study, patients had to fulfil the following criteria: having
received hypertension treatment for a minimum of three months and
being over 35 years of age. Before filling in the questionnaire,
informed consent was obtained from the participants. We ensured
anonymity to all respondents. Measures
We set up measures of key constructs in our conceptual model as
well as other potential factors of adherence.
The patients’ behavioural non-adherence to drug regimens was
measured on a 15-item scale developed based on the Medication
Adherence Report Scale (MARS).20 We added ten items  to the original
5-item measure,21-23 which allowed us to create two separate sub-scales
for intentional and unintentional non-adherence.
Respondents’ functional health literacy was measured using the
Newest Vital Sign (NVS). This is a performance-based measurement
consisting of a nutritional product label accompanied by 6 questions.24
The Judgment Skills measure consists of four scenarios which
describe typical everyday situations in disease management.10,11 The
patients are instructed to indicate which behaviour they would most
likely engage in when faced with the situation described in the sce-
nario. As the potential behaviours differ in biomedical adequacy, the
four options are then ranked.10,11
The Health Empowerment Scale was used based on the measure pro-
posed by Spreitzer,25 adapted to the hypertension condition. The tool
measures four facets of empowerment: Competence, Meaningfulness,
Impact and Self-determination.
The Medication Adherence Self-Efficacy Scale (MASES) is a 13-item
scale assessing patients’ confidence in their ability to take their anti-
hypertensive medication in a variety of situations.26
Beliefs about Medicines Questionnaire (BMQ) is an 11-item meas-
ure, consisting of two sub-scales.14,27 The Necessity subscale measures
the perceived need for the medication(s), while the Concern sub-scale
assesses concerns about potential negative effects such as dependence
or side effects.
Participants’ acceptance of treatment advice was measured with a
modified 4-item scale assessing the extent to which the participants
found the medical advice acceptable, clear and reasonable, and their
level of satisfaction with the received information. 17
We assessed the following socio-demographic variables: age, gender,
educational attainment, health related education, employment status,
marital status, family members living in the same household and lin-
guistic background. Respondents were also asked to provide clinical
information about the disease duration, and comorbidities. Regarding
the medication regimen, the following information was obtained: the
name of the prescribed medication(s), the frequency of its daily
assumption and the side effects the respondents experienced.Analysis
Descriptive statistics are reported as mathematical means and stan-
dard deviations. The Pearson correlation coefficient was used to deter-
mine the association between the scales. The outcomes of the adherent
and non-adherent groups on the scales mentioned were compared with
independent samples t-tests. Finally, a mediation analysis was per-
formed.
ResultsThe socio-demographic and clinical antecedents ofmedication adherence
The sample consists of 109 hypertension patients (male: 69) holding
at least one medical prescription. Table 1 shows the socio-demographic
and clinical characteristics.
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Table 1. The means and standard deviation of the socio-demographic and clinical characteristics of the sample (N=109)
Intentional (non-)adherence                                 Unintentional (non-)adherence
                         Complete                       Occasional                        Complete            Occasional 
                          adherence   non-adherence      adherence          non-adherence    
                            (N=56) (N=53) (N=49)              (N=60)
                                          Mean                 SD          Mean               SD                  Mean                 SD                   Mean                     SD
Age (years)                                    64.29                        9.78              61.94                    13.29                       66.70                        9.48                          60.19                            12.42
Illness duration (in years)        11.97                        9.33              10.91                     9.27                        11.85                        8.55                          11.15                             9.95
Side effects (0-10)                       1.61                         1.53               2.06                      1.93                         1.19                          0.9                            2.34                              2.07
Number of daily pills                    1.71                         1.16               1.74                      1.21                         1.58                         0.77                           1.83                              1.42
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The intentional and unintentional adherence scores were
dichotomized due to the high level of adherence in the sample: partic-
ipants were divided into two groups: complete adherence (respondents
who achieved a maximum score on the scale, i.e. 100% adherence) and
occasional non-adherence (those who scored lower than the maxi-
mum). There was a moderate positive association between the inten-
tional and unintentional adherence scales (r=0.493, P<0.001).
Patients reporting occasional unintentional non-adherence behav-
iours are significantly younger than those who are completely adherent
(t=-2.97; P=0.004), while there was no age difference in the case of the
intentionally adherent and non-adherent groups (t=-1.03; P=0.29).
Gender did not have a significant effect either on intentional or unin-
tentional non-adherence.
People who were intentionally completely adherent versus intention-
ally occasionally non-adherent did not differ in terms of the duration of
their illness, the side effects experienced, the number of medications
being taken or the number of pill assumption per day. The results look
extremely similar in the case of the unintentional non-adherence, with
the exception that patients engaging in occasional unintentional non-
adherence experienced significantly more side effects than adherent
patients (t=-3.54; P=0.001).The cognitive and psychological factors of medicationadherence
Patients who engaged occasionally in intentional non-adherence
behaviour reported lower adherence self-efficacy (t=-4.54, P<0.001),
higher medication concern beliefs (t=2.13; P=0.03), lower
Empowerment Meaningfulness scores (t=-2.50; P=0.01) and accepted
to a lesser extent their doctor’s treatment recommendations (t=2.29;
P=0.02). No statistically significant differences have been found for
the Empowerment Impact (t=0.01; P=0.99), the Empowerment Self-
determination (t=1.38; P=0.16), the Empowerment Competence (t=
0.45; P=0.65), the NVS (t=1.21; P=0.22), the Judgment skills (t=-0.38;
P=0.40) or the MBQ Necessity scores (t=-1.05; P=0.29).
The same pattern was found when analysing the unintentional non-
adherence determinants: lower adherence self-efficacy (t=-3.15,
P=0.002), higher medication concern beliefs (t=-2.96; P=0.004), lower
Empowerment Meaningfulness scores (t=-2.32; P=0.02) and lower
acceptance of the doctor’s treatment recommendations (t=-1.95;
P=0.05) characterized those who engaged occasionally in unintention-
al non-adherence behaviours than the completely adherent patients.
No statistically significant difference was found for the Empowerment
Impact (t=-1.75; P=0.08), the Empowerment Self-determination
(t=0.75; P=0.45), the Empowerment Competence (t=0.60; P=0.54), the
NVS (t=-1.29; P=0.19), the Judgment skills (t=-1.15; P=0.25) or the
MBQ Necessity scores (t=-1.11; P=0.26) (Table 2).Mediation analysis
Based on the results of binomial logistic regression, a mediation
analysis was performed to test the hypothesis that adherence self-effi-
cacy (MASES) mediates the effect of functional health literacy (HL) on
intentional non-adherence. Patients’ acceptance of their doctor’s
advice was incorporated into the model as a covariate. No significant
direct effect of HL was seen on intentional non-adherence (b=-0.08,
SE=0.15, z=-0.57, P=0.56). HL was a significant predictor of the
MASES (b=1.10, SE=0.36, t=3.02, P<0.003) and the MASES was a sig-
nificant predictor of intentional non-adherence (b=0.26, SE=0.07,
t=3.63, P<0.001). No significant effect of Patients’ acceptance of the
doctor’s advice was found. The indirect effect was tested using a boot-
strap estimation approach with 1000 samples, and analysis showed that
the indirect coefficient was significant (b=0.28, SE=0.15,
95%CI=0.0963, 0.7323). Finally, approximately 25% of the variance in
the intentional non-adherence score was accounted for by the predic-
tors (CoxSnell R2=0.2518; Nagelkrk R2=0.33). To sum up, these results
support the mediation hypothesis that MASES can be considered to be
a full mediator between HL and intentional non-adherence.
Discussion and Conclusions
Adherent patients were characterized as having a higher level of
adherence self-efficacy, which is one of the most prominent predictors
of adherence mentioned in literature.13 As for empowerment, the
Meaningfulness dimension is the most important predictor, i.e. if
patients consider their hypertension control activities worth investing
energy in, they comply more with their medication regimens. Besides
this, medication beliefs also play a role in influencing medication
adherence, i.e. patients who endorse concern beliefs about their med-
ication tend to adhere less to their medication regimens. Our findings
are in accordance with previous meta-analysis which showed that in
cases of cardiovascular disease, endorsing medication concern beliefs
is a more important predictor of non-adherence than endorsing neces-
sity beliefs.15 A qualitative review also reported that one of the main
reasons behind hypertension patients’ intentional non-adherence was
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Table 2. The internal consistency and the means and standard deviations of the scales.
The scales               Cronbach’s    Score Intentional (non-)adherence                           Unintentional (non-adherence)
                                     alpha        range Complete      Occasional        Complete            Occasional
                                                            adherence non-adherence adherence      non-adherence
                                                                         Mean               SD           Mean             SD              Mean              SD               Mean           SD
NVS                                           0.733                0-6                 4.42                      1.62                4.03                   1.74                    4.46                    1.54                     4.05                 1.78
MASES                                      0.941              13-52              48.84                    3.65               43.64                  7.68                   48.39                   4.66                    44.61                7.25
MB Concern                            0.872               6-30               14.11                    5.46               16.58                   5.6                    13.36                   4.68                    16.78                5.91
MB Necessity                         0.842               5-25               19.41                    3.46               18.61                  3.81                   19.47                   3.51                    18.62                3.74
Empowerment                                                                                                                                                                                                                                                                  
         Meaningfulness           0.612                1-7                 6.20                      1.19                5.67                   1.01                    6.22                    1.18                     5.72                 1.05
         Impact                            0.902                1-7                 4.75                      1.95                4.75                   1.63                    5.08                    1.88                     4.47                 1.69
         Self-determination      0.821                1-7                 3.61                      2.10                4.12                   1.75                    3.70                    2.04                     3.99                 1.87
         Competence                 0.629                1-7                 5.04                      1.59                5.17                   1.46                    5.20                    1.57                     5.02                 1.50
Patients’ acceptance            0.953                1-7                 6.56                      0.75                6.09                   1.21                    6.56                    0.78                     6.16                 1.15
of the doctor’s advice               
Judgment skills                          -                    1-4                 3.60                      0.40                3.66                   0.28                    3.67                    0.33                     3.60                 0.35
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a concern about drug side effects, e.g. developing an addiction.28
Additionally, adherent patients reported higher acceptance of their doc-
tor’s medical advice. Previously, a positive link was found between the
participants’ acceptance of medical advice and participants’ intention
to adhere to the given recommendation in an experiment.17 Our out-
comes confirm that if the patients’ believe that they have received clear
and reasonable medical recommendations supported with arguments,
this is then associated with the patients’ self-reported behavioural
medication adherence. The analysis did not reveal any significant dif-
ference in terms of the underpinning cognitive or emotional factors of
intentional versus unintentional medication non-adherence. However,
the findings have to be treated with caution, as intentional and unin-
tentional adherence show a positive moderate correlation in our sam-
ple. We found significant differences in the socio-demographic and
clinical factors, i.e. unintentionally occasionally non-adherent patients
were younger and had experienced more side effects compared to the
adherent patients, but there was no such difference in the case of
intentional adherence. The finding that younger participants report
higher unintentional non-adherence was unexpected and might be
explained by lifestyle factors, as older patients might dedicate more
time to following their medication regimen and there are many adher-
ence aids available to and more likely to be used by the elderly, such as
pill boxes and calendars.29 The results support the proposition that the
clinical and socio-demographic determinants of deliberate and non-
deliberate non-adherence should be investigated separately.18,30,31
Contrary to our expectations, health literacy was not a direct predic-
tor of medication adherence. The mediation analysis revealed that
health literacy is an indirect positive determinant of intentional med-
ication adherence, and medication adherence self-efficacy mediates
this relationship. Similarly, previous studies also reported that self-effi-
cacy was a mediator of health literacy on adherence to self-care behav-
iours in kidney transplant patients32 and to medication adherence in
HIV.33 These findings are in accordance with reviews which advocated
that health literacy in itself cannot account for medication adherence,
but that other variables should also be taken into consideration.7,8,34 We
suggest that self-efficacy is an important mediator of the effect of
health literacy on medication adherence. Moreover, besides health lit-
eracy and self-efficacy, patients’ acceptance of their doctor’s advice was
a covariate in the present model, so it is also an important factor in
terms of medication adherence. To sum up, high level functional health
literacy coupled with high adherence self-efficacy and a patient’s satis-
faction with their doctor’s advice promote intentional medication
adherence. However, judgment skills did not significantly influence the
level of medication adherence. Thus, functional literacy skills seem to
be more important in determining adherence, while judgment skills
and other complex cognitive skills relative to health literacy concepts
may tend to influence other aspects of disease management.
The present study is not without limitations. First of all, the major
limitation of the study is that the prevalence of non-adherence is low in
the sample. Based on the literature, patients are generally considered
non-adherent if they take less than 80% of their medicines as ascer-
tained by an objective adherence measure.3,35 Dichotomization is a
common and a justified practice in research,36 patients are usually cat-
egorized as either adherent or non-adherent. However, in the present
study the majority of the participants reported a high level of medica-
tion adherence; thus we applied another dichotomization: comparing
the patients who reported complete adherence (having a maximum
score on the adherence scale) and patients who reported occasional
non-adherence (achieving less than the 100% score on the adherence
measure). Taking into consideration this limitation, we argue that dif-
ferentiating between completely adherent and occasionally non-adher-
ent patients − providing a fine-grained assessment of differentiation
between relatively high levels of adherence − should also be a relevant
part of adherence research. Secondly, the principles for measuring
intentional and unintentional adherence are not standardized yet;
these trends showing a moderate positive association. Thirdly, our
sample size was small. Forth, the study was cross-sectional, so we can-
not derive conclusions about potential causal relationships. Finally, the
patients engaging in occasional unintentional non-adherence experi-
enced significantly more side effects compared to the adherent
patients. The difference in the experienced side effects between
patients might have had a stronger effect on their adherence level com-
pared to the psychological and cognitive factors. Further qualitative
research might explore how the differences in the clinical and psy-
chosocial characteristics influenced patients’ medication adherence.
This study highlights practical implications for promoting patients’
medication adherence. First of all, it would be worth checking up on
patients’ acceptance of treatment advice after their medical consulta-
tion; and since a previous study showed that if patients have received
reasonable arguments from their health care professionals supporting
the treatment recommendations, this increases their acceptance of
advice.17 Thus, motivating physicians and nurses to provide arguments
can be a potential new approach to support shared decision mak-
ing,17,37-39 and this in turn would increase patients’ adherence. This is
especially important for patients characterized with lower adherence
self-efficacy, as these patients are more likely to engage in occasional
non-adherence. Another potential way to increase medication adher-
ence is through increasing patients’ adherence self-efficacy. In partic-
ular, doctors and nurses might discuss certain situations with their
patients which the patients appear to find particularly challenging
when following their prescribed medication regimen. Talking over
patients’ medication concerns can also lessen their non-adherence
behaviour.15,40 Regarding the research implications, health literacy and
self-efficacy should be assessed simultaneously when investigating the
factors of non-adherence. Moreover, patients’ acceptance of their doc-
tor’s advice should also be taken into consideration. Besides this,
future research with a greater sample size might further investigate
the background factors and causes of intentional and unintentional
non-adherence with separate samples only showing either intentional
or unintentional non-adherence.
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